Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors

Abstract

Although immune checkpoint blockade (ICB) holds potential for the treatment of various tumors, a considerable proportion of patients show a limited response to ICB therapy due to the low immunogenicity of a variety of tumors. It has been shown that some chemotherapeutics can turn low-immunogenic tumors into immunogenic phenotypes by inducing a cascade of immune responses. In this paper, we synthesized an injectable micelle-incorporated hydrogel, which was able to sequentially release the chemotherapeutic gemcitabine (GEM) and the hydrophobic indoleamine 2, 3-dioxygenase inhibitor, d-1-methyltryptophan (d-1MT) at tumor sites. The hydrogel was formed via the thiol–ene click reaction between the thiolated chondroitin sulfate and the micelle formed by amphiphilic methacrylated Pluronic F127, in which hydrophobic d-1MT was encapsulated in the core of the F127 micelles and the hydrophilic GEM was dispersed in the hydrogel network. The successive release of chemotherapeutics and immune checkpoint inhibitors at tumor tissues will first promote the infiltration of cytotoxic T lymphocytes and subsequently induce a robust antitumor immune response, ultimately exerting a synergetic therapeutic efficacy. In a 4T1 tumor-bearing mice model, our results showed that the combination of chemotherapy and immunotherapy through the micelle-incorporated hydrogel triggered an effective antitumor immune response and inhibited tumor metastasis to the lung. Our results highlight the potential of the injectable micelle-incorporated hydrogel for the localized chemo-immunotherapy in the treatment of breast tumors.

Self-Healing Injectable Hydrogels for Tissue Regeneration

“…Both therapies have shown promising results against a variety of cancers but are still limited by low response rates and side effects. Self-healing injectable hydrogels can be exploited for a more targeted delivery of immune checkpoint inhibitors − or CAR T-cells − to achieve higher local effective doses and increase cell survival while reducing off-target side effects. The effectiveness of cancer therapies is often impeded by the immunosuppressive tumor microenvironment.…”

Injectable Bioadhesive Hydrogels Scavenging ROS and Restoring Mucosal Barrier for Enhanced Ulcerative Colitis Therapy

“…The presence of peaks at 2.41 and 2.58 ppm in the 1 H NMR spectrum attributed to the methylene group of 2-MEA indicated the successful synthesis of CS-SH (Figure S2). 56 When CS-SH was added into the PDA solution at a concentration of 20% (w/v) under vortex-induced mixing, the sol−gel transition could be clearly observed within about 1 h (Figure 1A). It could still keep the gel structure even after injection using a syringe.…”

A self-healable metallohydrogel for drug encapsulations and drug release

“…Chemotherapy uses cytotoxic chemicals. 28 Delivering therapeutic agents to the channel is the most significant hurdle for cancer treatment. Typically, the drug is placed into a carrier medium and transported to the desired spot.…”